There is a serious risk that variants are evading the vaccines. We don't know, but the if they do, we may need to return to social distancing, lock downs etc.
2/N
We know that we need up to 6 months to plan such a campaign (get the manufacturing right, prepare the logistics, etc.)
3/N
Option 1: we wait and understand better
Option 2: we launch now
4/N
Option 1: We wait - What happens?
A/ If the variants are not evading, it was the optimal cost option
B/ If the variants are evading, we risk 3 months delay (as UK and US are first) and full lockdown for months
5/N
Option 2: We launch now - What happens?
1/ If the variants are not evading, we will have had costs for nothing (but can still give the doses away as part of COVAX)
2/ If the variants are evading, we will be ready to limit impact
6/N
Clearly, the UK goes (as in March 2020), for option 2
Question: what should 🇪🇺 do?
N/N
In summary
➡️Yes we don't know if future vaccines will be effective against variants
➡️Yes we don't know if our current vaccines will be effective
➡️But we do know that if we don't start now, we leave the impact of variants to pure luck
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Vaccination in 🇧🇪: More delays were announced and there is real confusion about what Belgian really ordered. So here a thread on
/ Supply and deliveries
/ Likely vaccination plan
/ Immunization plan
The result is not cheerful but a reset requires facing the harsh reality⬇️⬇️⬇️
First things first: 🇧🇪 ordered less than others for 2021
We took
- 50% of 1st Moderna Contract (2m not 4m)
- 50% of 2nd Moderna Contract (3.8 not 7.8m) of which 50% is delivered in S2 2021 (rest in 2022)
- 50% of Curevac (2.9m not 5.8m)
1/N
Let's reuse the graph for some side comments
/ 🇬🇧 invested boldly in AZ and this pays off at the moment
/ 🇩🇪 got the surplus of other EU countries (NB: there is still an element of estimation: actual could be slightly lower in the end)